Risk of relapse or progression remains high in the treatment of most patients with epithelial ovarian cancer, and development of a molecular predictor could be a valuable tool for stratification of patients by risk. We aimed to develop a microRNA (miRNA)-based molecular classifier that can predict risk of progression or relapse in patients with epithelial ovarian cancer.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
DI MAIO, Massimo;
2016-01-01
Abstract
Risk of relapse or progression remains high in the treatment of most patients with epithelial ovarian cancer, and development of a molecular predictor could be a valuable tool for stratification of patients by risk. We aimed to develop a microRNA (miRNA)-based molecular classifier that can predict risk of progression or relapse in patients with epithelial ovarian cancer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
manuscript accepted with tables-figures.pdf
Open Access dal 30/10/2018
Descrizione: Articolo principale, con tabelle e figure
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
679.58 kB
Formato
Adobe PDF
|
679.58 kB | Adobe PDF | Visualizza/Apri |
|
Supplementary informationR2.pdf
Open Access dal 30/10/2018
Descrizione: materiale supplementare
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
569.69 kB
Formato
Adobe PDF
|
569.69 kB | Adobe PDF | Visualizza/Apri |
|
1-s2.0-S1470204516301085-main.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
557.54 kB
Formato
Adobe PDF
|
557.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
